Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides

PLoS ONE(2021)10.1371/journal.pone.0241157Source: DataRank Database

Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

uniprot pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Hideaki Mabashi‐Asazuma ORCID,Donald L. Jarvis ORCID,Kazuhiko Yamasaki ORCID,Tomoya O. Akama ORCID,Masato Nagaoka

Live enrichment

PubMed:33406123 PMC:PMC7787448 OpenAlex:https://openalex.org/W33406123

National Institutes of Health

Grant: P41-GM103390

National Institutes of Health

Grant: P41-RR005351

Japan Agency for Medical Research and Development

Grant: P-CREATE

Nakajima Foundation

Grant: Research Grant for Young Japanese Scientists

NCRR NIH HHS

Grant: P41 RR005351

NIGMS NIH HHS

Grant: P41 GM103390

NCI NIH HHS

Grant: P30 CA030199

National Institutes of Health

Grant: 3P41RR005351-20S2

Research Resource for Integrated Glycotechnology

National Institutes of Health

Grant: 2P41GM103390-26

Training

goldLicense: cc-by

journalhttp://lib.unnes.ac.id/15666/

publisherhttps://doi.org/10.1371/journal.pone.0241157

publisherhttps://dx.plos.org/10.1371/journal.pone.0241157

repositoryhttps://doaj.org/article/5d129291cb2948fdaf1c7fd0544d7567

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7787448

Fields of Study

Financial Analysis and Corporate GovernanceIslamic Finance and CommunicationIslamic Finance and Banking Studies0301 basic medicine03 medical and health sciences

MeSH Terms

AnimalsMice, Inbred BALB CHumansMiceMice, NudeBrain NeoplasmsNeovascularization, PathologicPeptidesAnnexin A1Neoplasm ProteinsDrug Delivery SystemsAdministration, OralXenograft Model Antitumor Assays

Keywords

Business administrationBusinessMathematicsMice, Inbred BALB CNeovascularization, PathologicBrain NeoplasmsScienceQRAdministration, OralMice, NudeXenograft Model Antitumor AssaysNeoplasm ProteinsMiceDrug Delivery SystemsMedicineAnimalsHumansPeptidesResearch ArticleAnnexin A1

Sustainable Development Goals

SDG 3: 3. Good healthSDG 14: 14. Life underwaterSDG 0: Partnerships for the goals

Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides

FAIR Checklist

Authors (13)

Funding (9 grants)

Open Access

Topics

Annotations (Europe PMC)